SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?


To: kha vu who wrote (56855)8/22/1999 11:35:00 AM
From: kendall harmon  Respond to of 120523
 
Jenna:

The basic difference, I can't speak for Jeff, of course but for me I need some fundamental information on the company to make the plunge. I think the fundamental knowledge of a company gives a trader a decided 'edge' in his decision of how low to put his stop, historical volatility of a stock around earnings time, and generally if there is an undecided signal which can go both ways, especially for the swing trade, which is what I like the best as well. The fundamental condition of the stock will help me with the final decision.

This says it eloquently in terms of how I approach things. A stock is moving, volume is picking up, someone is talking about it on some thread, and I still sit there and will not enter until I can give a one sentence cogent reason as to WHY. One way I look at it is it is the Peter Lynch principle as applied to short term trading. Know the company and how the stock.

In theology, Karl Barth once said exegesis, exegesis, and more exegesis (which means: study the text, study the text, study the text). In trading, it comes down to research, research and more research.

One practical application of this to the MG thread is that if you enter a stock and SAY WHY you do so it is so much more helpful to the rest of us. JNJ on Friday morning is a good example of this. I saw it moving on good volume but it was when I saw the FDA news that I went in. I posted this news with my post on JNJ. That way others can use our posts to do their own research.